Staphylococcal SSL5-induced platelet microparticles provoke proinflammatory responses via the CD40/TRAF6/NFKB signalling pathway in monocytes

Summary

Pathogens-induced platelet activation contributes to inflammation in cardiovascular diseases, but underlying mechanisms remain elusive. Staphylococcal superantigen-like protein 5 (SSL5) is a known activator of platelets. Here we examined whether SSL5 is implicated in Staphylococcus aureus (S. aureus)-induced inflammation and potential mechanisms involved. As expected, we show that SSL5 activates human platelets and induces generation of platelet microparticles (PMPs). Flow cytometry and scanning electron microscopy studies demonstrate that SSL5-induced PMPs (SSL5-PMPs) bind to monocytes, causing aggregate formation. In addition, SSL5-PMPs provoke monocyte expression and release of inflammatory mediators, including interleukin-1β (IL-1β), tumour necrosis factor-α (TNFα), monocyte chemoattractant protein-1 (MCP-1) and matrix metalloproteinase-9 (MMP-9) in a dose- and time-dependent manner. SSL5-PMPs also enhance MCP-1-induced monocyte migration. Blockade of CD40 and CD40 ligand (CD40L) interactions with neutralising antibodies significantly reduce monocyte release of inflammatory mediators and migration induced by SSL5-PMPs. SiRNA-mediated silencing of CD40 or TNF receptor (TNFR)-associated factor 6 (TRAF6) gene largely abrogates phosphorylation and nuclear translocation of NFkB (p65). In conclusion, SSL5 provokes the release of inflammatory mediators in monocytes, at least in part, via PMPs-mediated activation of the CD40/TRAF6/NFkB signalling pathway, though it normally inhibits leukocyte function. Our findings thus reveal a novel mechanism by which S. aureus induces inflammation.

Keywords

Staphylococcal superantigen-like protein 5 - platelet microparticles - monocytes - inflammation - CD40 ligand

• References

• 1 Kern WV Management of Staphylococcus aureus bacteremia and endocarditis: progresses and challenges. Curr Opin Infect Dis 2010; 23: 346-358.
• 2 Adhikari RP, Ajao AO, Aman MJ. et al. Lower antibody levels to Staphylococcus aureus exotoxins are associated with sepsis in hospitalized adults with invasive S. aureus infections. J Infect Dis 2012; 206: 915-923.
• 3 Fitzgerald JR, Foster TJ, Cox D. The interaction of bacterial pathogens with platelets. Nat Rev Microbiol 2006; 4: 445-457.
• 4 Cox D, Kerrigan SW, Watson SP. Platelets and the innate immune system: mechanisms of bacterial-induced platelet activation. J Thromb Haemost 2011; 9: 1097-1107.
• 5 Powers ME, Bubeck Wardenburg J. Igniting the fire: Staphylococcus aureus virulence factors in the pathogenesis of sepsis. PLoS Pathog 2014; 10: e1003871.
• 6 O’Brien L, Kerrigan SW, Kaw G. et al. Multiple mechanisms for the activation of human platelet aggregation by Staphylococcus aureus: roles for the clumping factors ClfA and ClfB, the serine-aspartate repeat protein SdrE and protein A. Mol Microbiol 2002; 44: 1033-1044.
• 7 Fitzgerald JR, Loughman A, Keane F. et al. Fibronectin-binding proteins of Sta-phylococcus aureus mediate activation of human platelets via fibrinogen and fi-bronectin bridges to integrin GPIIb/IIIa and IgG binding to the FcgammaRIIa receptor. Mol Microbiol 2006; 59: 212-230.
• 8 Bertling A, Niemann S, Hussain M. et al. Staphylococcal extracellular adherence protein induces platelet activation by stimulation of thiol isomerases. Arte-rioscler Thromb Vasc Biol 2012; 32: 1979-1990.
• 9 Berube BJ, Bubeck Wardenburg J. Staphylococcus aureus α-toxin: nearly a century of intrigue. Toxins 2013; 5: 1140-1166.
• 10 Williams RJ, Ward JM, Henderson B. et al. Identification of a novel gene cluster encoding staphylococcal exotoxin-like proteins: characterisation of the proto-typic gene and its protein product, SET1. Infect Immun 2000; 68: 4407-4415.
• 11 de Haas CJ, Weeterings C, Vughs MM. et al. Staphylococcal superantigen-like 5 activates platelets and supports platelet adhesion under flow conditions, which involves glycoprotein Ibalpha and alpha IIb beta 3. J Thromb Haemost 2009; 7: 1867-1874.
• 12 Hu H, Armstrong PC, Khalil E. et al. GPVI and GPIbalpha mediate staphy-lococcal superantigen-like protein 5 (SSL5) induced platelet activation and direct toward glycans as potential inhibitors. PLoS ONE 2011; 6: e19190.
• 13 Armstrong PC, Hu H, Rivera J. et al. Staphylococcal superantigen-like protein 5 induces thrombotic and bleeding complications in vivo: inhibition by an anti-SSL5 antibody and the glycan Bimosiamose. J Thromb Haemost 2012; 10: 2607-2609.
• 14 Semple JW, Italiano JE, Freedman J. Platelets and the immune continuum. Nat Rev Immunol 2011; 11: 264-274.
• 15 Morrell CN, Aggrey AA, Chapman LM. et al. Emerging roles for platelets as immune and inflammatory cells. Blood 2014; 123: 2759-2767.
• 16 Burnouf T, Goubran HA, Chou M-L. et al. Platelet microparticles: detection and assessment of their paradoxical functional roles in disease and regenerative medicine. Blood Rev 2014; 28: 155-166.
• 17 Woth G, Tokés-Füzesi M, Magyarlaki T. et al. Activated platelet-derived micro-particle numbers are elevated in patients with severe fungal (Candida albicans) sepsis. Ann Clin Biochem 2012; 49: 554-560.
• 18 Stępieñ E, Stankiewicz E, Zalewski J. et al. Number of microparticles generated during acute myocardial infarction and stable angina correlates with platelet activation. Arch Med Res 2012; 43: 31-35.
• 19 Skeppholm M, Mobarrez F, Malmqvist K. et al. Platelet-derived microparticles during and after acute coronary syndrome. Thromb Haemost 2012; 107: 1122-1129.
• 20 Mayne E, Funderburg NT, Sieg SF. et al. Increased platelet and microparticle activation in HIV infection: upregulation of P-selectin and tissue factor expression. J Acquir Immune Defic Syndr 2012; 59: 340-346.
• 21 Lo S-C, Hung C-Y, Lin D-T. et al. Involvement of platelet glycoprotein Ib in platelet microparticle mediated neutrophil activation. J Biomed Sci 2006; 13: 787-796.
• 22 Vasina EM, Cauwenberghs S, Feijge MAH. et al. Microparticles from apoptotic platelets promote resident macrophage differentiation. Cell Death Dis 2011; 2: e211.
• 23 Mause SF, Ritzel E, Liehn EA. et al. Platelet microparticles enhance the vasore-generative potential of angiogenic early outgrowth cells after vascular injury. Circulation 2010; 122: 495-506.
• 24 Zwicker JI, Lacroix R, Dignat-George F. et al. Measurement of platelet microparticles. Methods Mol Biol 2012; 788: 127-139.
• 25 Sun H, Li X-B, Meng Y. et al. TRAF6 upregulates expression of HIF-1a and promotes tumor angiogenesis. Cancer Res 2013; 73: 4950-4959.
• 26 Hawkes SP, Li H, Taniguchi GT. Zymography and reverse zymography for detecting MMPs, and TIMPs. Methods Mol Biol 2001; 151: 399-410.
• 27 Mukundan L, Bishop GA, Head KZ. et al. TNF receptor-associated factor 6 is an essential mediator of CD40-activated proinflammatory pathways in monocytes and macrophages. J Immunol 2005; 174: 1081-1090.
• 28 Lutgens E, Lievens D, Beckers L. et al. Deficient CD40-TRAF6 signalling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile. J Exp Med 2010; 207: 391-404.
• 29 Portillo J-AC, Greene JA, Schwartz I. et al. Blockade of CD40-TRAF2,3 or CD40-TRAF6 is sufficient to inhibit pro-inflammatory responses in non-haematopoietic cells. Immunology 2014; 144: 21-33.
• 30 Bestebroer J, van Kessel KPM, Azouagh H. et al. Staphylococcal SSL5 inhibits leukocyte activation by chemokines and anaphylatoxins. Blood 2008; 113: 328-337.
• 31 Badrnya S, Schrottmaier WC, Kral JB. et al. Platelets mediate oxidized low-density lipoprotein-induced monocyte extravasation and foam cell formation. Arte-rioscler Thromb Vasc Biol 2014; 34: 571-580.
• 32 Suttles J, Stout RD. Macrophage CD40 signalling: a pivotal regulator of disease protection and pathogenesis. Semin Immunol 2009; 21: 257-264.
• 33 Arman M, Krauel K, Tilley DO. et al. Amplification of bacteria-induced platelet activation is triggered by FcyRIIA, integrin aIIbβ3, and platelet factor 4. Blood 2014; 123: 3166-3174.
• 34 Hamzeh-Cognasse H, Damien P, Chabert A. et al. Platelets and infections -complex interactions with bacteria. Front Immunol 2015; 6: 82.
• 35 Vasina EM, Cauwenberghs S, Staudt M. et al. Aging- and activation-induced platelet microparticles suppress apoptosis in monocytic cells and differentially signal to proinflammatory mediator release. Am J Blood Res 2013; 3: 107-123.
• 36 Corrales-Medina VF, Fatemi O, Serpa J. et al. The association between Staphy-lococcus aureus bacteremia and acute myocardial infarction. Scand J Infect Dis 2009; 41: 511-514.
• 37 Dickerman SA, Abrutyn E, Barsic B. et al. The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: an analysis from the ICE Prospective Cohort Study (ICE-PCS). Am Heart J 2007; 154: 1086-1094.
• 38 Czepluch FS, Kuschicke H, Dellas C. et al. Increased proatherogenic monocyte-platelet cross-talk in monocyte subpopulations of patients with stable coronary artery disease. J Intern Med 2013; 275: 144-154.
• 39 Ziegler-Heitbrock L, Ancuta P, Crowe S. et al. Nomenclature of monocytes and dendritic cells in blood. Blood 2010; 116: e74-80.
• 40 Stansfield BK, Ingram DA. Clinical significance of monocyte heterogeneity. Clin Transl Med 2015; 4: 5.
• 41 Passacquale G, Vamadevan P, Pereira L. et al. Monocyte-platelet interaction induces a pro-inflammatory phenotype in circulating monocytes. PLoS ONE 2011; 6: e25595.
• 42 Pamukcu B, Lip GYH, Snezhitskiy V. et al. The CD40-CD40L system in cardiovascular disease. Ann Med 2011; 43: 331-340.
• 43 Lievens D, Zernecke A, Seijkens T. et al. Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis. Blood 2010; 116: 4317-4327.
• 44 Léveillé C, Bouillon M, Guo W. et al. CD40 ligand binds to alpha5beta1 integrin and triggers cell signalling. J Biol Chem 2007; 282: 5143-5151.
• 45 Zirlik A, Maier C, Gerdes N. et al. CD40 Ligand Mediates Inflammation Independently of CD40 by Interaction With Mac-1. Circulation 2007; 115: 1571-1580.
• 46 Haselmayer P, Grosse-Hovest L, Landenberg von P. et al. TREM-1 ligand expression on platelets enhances neutrophil activation. Blood 2007; 110: 1029-1035.
• 47 Simon DI, Chen Z, Xu H. et al. Platelet glycoprotein ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18). J Exp Med 2000; 192: 193-204.
• 48 Xie P, Hostager BS, Munroe ME. et al. Cooperation between TNF receptor-associated factors 1 and 2 in CD40 signalling. J Immunol 2006; 176: 5388-5400.
• 49 Shai E, Rosa I, Parguiña AF. et al. Comparative analysis of platelet-derived microparticles reveals differences in their amount and proteome depending on the platelet stimulus. J Proteomics 2012; 76 Spec No.: 287-296.
• 50 Bestebroer J, Poppelier MJJG, Ulfman LH. et al. Staphylococcal superantigen-like 5 binds PSGL-1 and inhibits P-selectin-mediated neutrophil rolling. Blood 2007; 109: 2936-2943.